Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR-1.4%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
-1.4%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025100.00%
2024-145.77%
202341.50%
2022-7966.74%
2021-21.06%
2020107.50%
2019-347.56%
2018-37.32%
2017122.14%
2016-46.15%